Varenicline
Varenicline 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Smoking Cessation、Electronic Cigarette Use。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
12 项
已进入 III/IV 期
4 个
开展国家和地区
暂未检索到
中国境内设点
药品与企业信息
研发企业
- University of Wisconsin, Madison
- University of California, San Diego
- M.D. Anderson Cancer Center
- Children's Hospital of Philadelphia
- Ottawa Heart Institute Research Corporation
- University of Kansas Medical Center
- Sir Mortimer B. Davis - Jewish General Hospital
- University of California, Berkeley
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
美国、加拿大、India、South Africa
正在招募患者的 Varenicline 研究
Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder
早期 I 期招募中美国NCT06582888Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
IV 期招募中美国NCT04604509Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
不适用招募中美国NCT06582693Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation
IV 期招募中加拿大NCT06832085Switching to E-cigarettes in Smokers Not Interested in Quitting
III 期招募中美国NCT05703672Aggressive Smoking Cessation Trial (ASAP)
III 期招募中加拿大NCT05257629Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment
IV 期招募中美国NCT07606625A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
不适用招募中美国NCT06118502New Strategies to Enhance Smoking Cessation
不适用招募中美国NCT06751927Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes
不适用招募中美国NCT05642715Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
II 期招募中美国NCT05181891V+PSF-M for Tobacco Cessation in HIV Care in India
III 期招募中美国IndiaNCT05786547Pain and Smoking Study 2.0: A Randomized Clinical Trial of Smoking Cessation Among Veterans With Chronic Pain
不适用招募中美国NCT06442514A Study Of Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation
II 期 / III 期招募中美国NCT07487818Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation
II 期招募中美国NCT07099638Treating Contact Lens Discomfort With Varenicline Solution Nasal Spray 0.03mg
不适用招募中美国NCT07705893Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease
II 期招募中美国NCT06679374The Avenues Study: Dual Use Cessation
IV 期招募中美国NCT06474299Switch or Quit R01
不适用招募中美国NCT06373679tDCS Plus Varenicline for Smoking Cessation
IV 期招募中加拿大NCT06798324Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study)
IV 期招募中美国NCT07145866E-cigarette Cessation in Adults Who Co-use Cannabis
IV 期招募中美国NCT06688539A Trial of Varenicline for E-cigarette Cessation
II 期招募中美国NCT07040566Evaluating Smoking Cessation Interventions for PWH in South Africa
II 期 / III 期招募中South AfricaNCT05413122
中国患者怎么争取用上这款药
目前境内暂未检索到设点，下面几条途径是更现实的选择，每条都有详细的中文做法。
查看完整申请指南本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。